The FutureTox IV Organizing Committee looks forward to bringing together basic, clinical, and regulatory scientists to translate toxicology in the 21st-century approaches into chemical risk assessment and regulatory decision-making impacting children’s health. The FutureTox IV Progress to Maturity: Predictive Developmental and Reproductive Toxicology for Healthy Children conference will be held November 14‒16, 2018, at the Westin Crystal City, Arlington, Virginia. There is growing concern about increased susceptibilities of children and infants to chemicals in the environment, the dearth of methods to measure these endpoints, and the importance of the entire scientific community to come together in events such as this forum to collectively address these important issues and together to move forward.
This Society of Toxicology (SOT) Contemporary Concepts in Toxicology (CCT) conference will focus on the following:
- Life Stage Progression
- Human Reproductive Cycle
- Chemicals in the Environment
- Pharmaceuticals and Medical Products
- Addressing Current Opportunities and Challenges for In Vitro Data and In Silico Models
To view the complete FutureTox IV agenda and to register, please visit the conference website.
The FutureTox series focuses on building the roadmap for 21st-century toxicology and risk assessment practices, utilizing in vitro data and in silico models for predictive toxicology, and taking the high-throughput risk assessment paradigm forward to address challenges in implementing the emerging big-data toolbox for risk assessment and regulatory decision-making.
As a member of the Scientific Liaison Coalition (SLC), ACT is a pleased to provide our members with this upcoming conference announcement.